Pancreatic Cancer Trial, Recruiting (NCT05737953)

Pancreatic Cancer Trial, Recruiting NCT05737953 Sponsor: Zhaoshen Li Condition: Pancreatic Cancer

Printed from Voxsanity (voxsanity.com.au) — NCT05737953 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Pancreatic Cancer

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People aged 18 or older, of any gender
People who have had imaging tests (such as ultrasound, CT scan, or MRI) that identified a cyst or suspected cystic tumour on the pancreas
People who have agreed to undergo surgical removal of the pancreatic cystic tumour
People (or their family members) who are willing to sign a consent form agreeing to take part in the research

Who may not be able to join:

Cases where the removed tissue does not contain any cystic material, or where cystic fluid cannot be collected during surgery
People who have already received cancer-related treatments such as radiotherapy, chemotherapy, or immunotherapy before surgery
People who have taken antibiotics within the week before surgery
People who are unwilling or unable to undergo surgical removal of the pancreatic cystic tumour
People (or their family members) who are not willing to sign the research consent form

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 28 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Shiyu Li, Changhai Hospital

Phone: 021-31166666

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT05737953

Sponsor: Zhaoshen Li

Phase: Not Applicable

Status: Recruiting

Condition: Pancreatic Cancer

Trial contact: 021-31166666

More information: https://clinicaltrials.gov/study/NCT05737953

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People aged 18 or older, of any gender
People who have had imaging tests (such as ultrasound, CT scan, or MRI) that identified a cyst or suspected cystic tumour on the pancreas
People who have agreed to undergo surgical removal of the pancreatic cystic tumour
People (or their family members) who are willing to sign a consent form agreeing to take part in the research

Who may not be able to join:

Cases where the removed tissue does not contain any cystic material, or where cystic fluid cannot be collected during surgery
People who have already received cancer-related treatments such as radiotherapy, chemotherapy, or immunotherapy before surgery
People who have taken antibiotics within the week before surgery
People who are unwilling or unable to undergo surgical removal of the pancreatic cystic tumour
People (or their family members) who are not willing to sign the research consent form

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 28 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Zhaoshen Li

Registry

ClinicalTrials.gov

Start date

1 March 2023

Est. completion

31 July 2025

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Types and concentrations of cfDNA and proteins contained in the vesicular fluid

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov